Association Between Mitochondrial DNA Content and Risk of Acute Leukemia
NCT03595969 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2020-07-10
Summary
Compelling epidemiological evidence indicates that alterations of mitochondrial DNA, including mutations and abnormal content of mitochondrial DNA (mtDNA), are associated with the initiation and development of acute lymphoblastic leukemia (ALL).The aim of this study was to explore association between mtDNA content in peripheral blood cells could be used as a risk predictor for ALL.
Conditions
- Lymphoblastic Leukemia in Children
Interventions
- DIAGNOSTIC_TEST
-
Relative copy number of mitochondrial DNA
Mitochondria are responsible for multiple cellular functions including regulation of energy production, modulation of oxidation-reduction status, generation of reactive oxygen species and apoptosis. Each mitochondrion possesses multiple copies of a mitochondrial genome comprised of independently replicating double stranded DNA (mtDNA).
Sponsors & Collaborators
-
Air Force Military Medical University, China
lead OTHER -
Chinese Academy of Medical Sciences
collaborator OTHER
Eligibility
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-11-01
- Primary Completion
- 2019-10-01
- Completion
- 2019-10-01
Countries
- China
Study Locations
More Related Trials
-
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia
NCT01139931 ·Status: COMPLETED
-
Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
NCT03079947 ·Status: UNKNOWN
-
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
NCT01434329 ·Status: COMPLETED
-
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia
NCT01119586 ·Status: COMPLETED
-
DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia
NCT00899366 ·Status: COMPLETED
-
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia
NCT01139333 ·Status: COMPLETED
-
Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia
NCT00898261 ·Status: COMPLETED
-
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
NCT00898079 ·Status: COMPLETED
-
DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer
NCT00899548 ·Status: COMPLETED
-
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
NCT04060485 ·Status: UNKNOWN
-
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
NCT04263935 ·Status: RECRUITING
-
S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
NCT00919425 ·Status: COMPLETED
-
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
NCT00899327 ·Status: UNKNOWN
-
Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma
NCT05693012 ·Status: UNKNOWN
-
The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia
NCT01010256 ·Status: TERMINATED
-
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia
NCT00897936 ·Status: COMPLETED
-
Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia
NCT05983172 ·Status: ENROLLING_BY_INVITATION
-
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors
NCT03596593 ·Status: UNKNOWN ·Phase: NA
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
NCT01520246 ·Status: COMPLETED
-
Biology Studies of Hematologic Cancers
NCT00923442 ·Status: ENROLLING_BY_INVITATION
-
Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882
NCT00898469 ·Status: COMPLETED
-
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
NCT01500499 ·Status: COMPLETED
-
Molecular Epidemiology of Lymphoma Patients
NCT00488553 ·Status: WITHDRAWN
-
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia
NCT01057095 ·Status: COMPLETED